My CART
Photobiomodulation Low intensity laser therapy for Alzheimer's disease

Photobiomodulation Low intensity laser therapy for Alzheimer's disease

Abstract Downregulation of brain-derived neurotrophic factor (BDNF) occurs early in Alzheimer's disease progression, and low-intensity laser therapy has been shown to prevent brain cell loss by upregulating BDNF. Downregulation of hippocampal brain-derived neurotrophic factor (BDNF) occurs early in the progression of Alzheimer's disease (AD). Since BDNF plays an important role in neuronal survival and dendritic growth, upregulation of BDNF may help rescue dendritic atrophy and cell loss in AD. Low-level laser therapy (LLLT) has been shown to modulate neuronal function in vitro and in vivo. Research Researchers from the Ministry of Education's Key Laboratory of Laser Life Sciences and the...

Read more

Sale

Unavailable

Sold Out